"non small lung cancer" trang 14 - tải miễn phí từ tailieunhanh
Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: A real-world evidence survey

Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: A real-world evidence survey
20    1    1
A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer

A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer
13    1    1
Common driver mutations and programmed death-ligand 1 expression in advanced non-small cell lung cancer in smokers and never smokers

Common driver mutations and programmed death-ligand 1 expression in advanced non-small cell lung cancer in smokers and never smokers
15    1    1
Development and validation of prognostic nomogram for T1-3N0M0 non-small cell lung cancer after curative resection

Development and validation of prognostic nomogram for T1-3N0M0 non-small cell lung cancer after curative resection
9    1    1
Skeletal muscle index is associated with long term outcomes after lobectomy for non-small cell lung cancer

Skeletal muscle index is associated with long term outcomes after lobectomy for non-small cell lung cancer
9    1    1
Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving frst-line immunotherapy: A multicenter retrospective study

Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving frst-line immunotherapy: A multicenter retrospective study
21    1    1
Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib

Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib
9    1    1
Associations between telomere attrition, genetic variants in telomere maintenance genes, and non-small cell lung cancer risk in the Jammu and Kashmir population of North India

Associations between telomere attrition, genetic variants in telomere maintenance genes, and non-small cell lung cancer risk in the Jammu and Kashmir population of North India
10    1    1
Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: A phase Ib study

Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: A phase Ib study
13    5    1
A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV non-small cell lung cancer

A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV non-small cell lung cancer
12    3    1
Intrathecal chemotherapy combined with systemic therapy in patients with refractory leptomeningeal metastasis of non-small cell lung cancer: A retrospective study

Intrathecal chemotherapy combined with systemic therapy in patients with refractory leptomeningeal metastasis of non-small cell lung cancer: A retrospective study
11    4    1
A real-world study of Afatinib plus ramucirumab in treatment-naïve, EGFRmutated, non–small cell lung cancer

A real-world study of Afatinib plus ramucirumab in treatment-naïve, EGFRmutated, non–small cell lung cancer
8    6    1
Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non–small cell lung cancer: A modelling approach

Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non–small cell lung cancer: A modelling approach
10    7    1
Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements

Survival differences between patients with de novo and relapsed/progressed advanced non-small cell lung cancer without epidermal growth factor receptor mutations or anaplastic lymphoma kinase rearrangements
12    6    1
Clinical benefit of pembrolizumab in treatment of first line non-small cell lung cancer: A systematic review and meta-analysis of clinical characteristics

Clinical benefit of pembrolizumab in treatment of first line non-small cell lung cancer: A systematic review and meta-analysis of clinical characteristics
17    7    1
The timing of durvalumab administration affects the risk of pneumonitis in patients with locally advanced non-small cell lung cancer: A systematic review and meta-analysis

The timing of durvalumab administration affects the risk of pneumonitis in patients with locally advanced non-small cell lung cancer: A systematic review and meta-analysis
12    7    1
Genome-wide DNA methylation signature predict clinical benefit of bevacizumab in non-small cell lung cancer

Genome-wide DNA methylation signature predict clinical benefit of bevacizumab in non-small cell lung cancer
10    1    1
Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling

Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling
10    1    1
Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non–small-cell lung cancer patients: A prospective observational study

Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non–small-cell lung cancer patients: A prospective observational study
10    5    1
Efficacy and safety analyses of epidermal growth factor receptor tyrosine kinase inhibitors combined with chemotherapy in the treatment of advanced non–small-cell lung cancer with an EGFR/TP53 co-mutation

Efficacy and safety analyses of epidermal growth factor receptor tyrosine kinase inhibitors combined with chemotherapy in the treatment of advanced non–small-cell lung cancer with an EGFR/TP53 co-mutation
12    5    1